Novel Head and Neck Cancer Study Using a Vaccine
Head and neck cancer patients are being recruited to a clinical trial AHEAD-MERIT which makes use of BNT113 , a cancer vaccine. The trial will compare the use of BNT113 and pembrolizumab to using pembrolizumab alone. It is aimed at patients whose cancer has come back or metastasised and is linked to the human papilloma […]